U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H27NO4
Molecular Weight 345.4327
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BEVANTOLOL, (R)-

SMILES

COC1=CC=C(CCNC[C@@H](O)COC2=CC(C)=CC=C2)C=C1OC

InChI

InChIKey=HXLAFSUPPDYFEO-QGZVFWFLSA-N
InChI=1S/C20H27NO4/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3/t17-/m1/s1

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy.
2002 Dec
Determination of bevantolol in human plasma by high performance liquid chromatography using solid phase extraction technique.
2007 Jul
Determination of bevantolol enantiomers in human plasma by coupled achiral-chiral high performance-liquid chromatography.
2007 Jul
Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol.
2007 Jul 12
Patents
Name Type Language
BEVANTOLOL, (R)-
Common Name English
(+)-BEVANTOLOL
Common Name English
2-PROPANOL, 1-((2-(3,4-DIMETHOXYPHENYL)ETHYL)AMINO)-3-(3-METHYLPHENOXY)-, (2R)-
Systematic Name English
Code System Code Type Description
CAS
135531-40-7
Created by admin on Sat Dec 16 10:49:02 GMT 2023 , Edited by admin on Sat Dec 16 10:49:02 GMT 2023
PRIMARY
FDA UNII
34P43RW460
Created by admin on Sat Dec 16 10:49:02 GMT 2023 , Edited by admin on Sat Dec 16 10:49:02 GMT 2023
PRIMARY
PUBCHEM
36690919
Created by admin on Sat Dec 16 10:49:02 GMT 2023 , Edited by admin on Sat Dec 16 10:49:02 GMT 2023
PRIMARY